Keya Medical
AI for Smarter Healthcare
Keya Medical Joins Bayer’s Calantic AI Solution for Radiology
Keya Medical is thrilled to showcase its AI-based augmented CT-FFR analysis through Bayer’s Calantic Digital Solutions platform at ECR2024. Contact us to learn more about our augmentative AI-based CT-FFR analysis.
DVFFR by Keya Medical Matches Invasive FFR in Case Study at Clemenceau Medical Center
A case study at Clemenceau Medical Center in Beirut, Lebanon, shows that Keya Medical’s DeepVessel FFR (DVFFR) delivers results nearly identical to invasive FFR in assessing intermediate coronary artery stenosis. The findings demonstrate DVFFR’s value as a precise, non-invasive tool for guiding clinical decisions and avoiding unnecessary procedures.
Diagnostic Solutions
Treatment Solutions
Solution Suites
Cardiology
Neurology
Pulmonology
Pathology
General Surgery
Cardio Suite
Stroke Suite
Diagnostic Solutions
Cardiology
Neurology
Pulmonology
Pathology
Treatment Solutions
Vascular Surgery
General Surgery
Solutions Suites
Cardio Suite
Stroke Suite
DeepVessel® FFR
Enabling better diagnosis and treatment of patients with coronary artery disease.
DEEPVESSEL FFR is a AI-enabled, non-invasive CT fractional flow reserve (FFRCT) analysis. It is an augmentative physiological functional assessment of the coronary arteries using coronary computer tomography angiograms. The software can reduce unnecessary invasive testing, improve patient safety, and lower the cost of cardiovascular testing.
DEEPVESSEL FFR is FDA Cleared, CE Marked, and NMPA Approved.
FFRCT and DVFFR have transformed my practice, allowing me to provide superior patient care and achieve better outcomes. I am sincerely grateful for this invaluable resource provided by Corazon Imaging.
Scaling your Cardiovascular CT Service and Implementing CT-FFF
Discover the power of automated CT-FFR integration in enhancing your cardiovascular CT services. Learn from Dr. John A Rumberger, Dr. Scott Flamm, and Ralph Gentry how to simplify CT FFR implementation and scale your services.
DVFFR by Keya Medical Matches Invasive FFR in Case Study at Clemenceau Medical Center
A case study at Clemenceau Medical Center in Beirut, Lebanon, shows that Keya Medical’s DeepVessel FFR (DVFFR) delivers results nearly identical to invasive FFR in assessing intermediate coronary artery stenosis. The findings demonstrate DVFFR’s value as a precise, non-invasive tool for guiding clinical decisions and avoiding unnecessary procedures.
Comprehensive R&D Pipeline Solution Suites
Keya Medical is developing a comprehensive R&D pipeline to deliver clinical value throughout the patient care process. The product candidates in our pipeline will be designed for use in early screening, diagnosis, treatment, and post-treatment followup.
Keya Medical: leading AI medical device company
Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Keya Medical has four centers of excellence in Beijing, Shanghai, Shenzhen, and Seattle. To learn more about Keya Medical, follow us on LinkedIn, Twitter, and Facebook.
Latest News
Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights.
DVFFR by Keya Medical Matches Invasive FFR in Case Study at Clemenceau Medical Center
A case study at Clemenceau Medical Center in Beirut, Lebanon, shows that Keya Medical’s DeepVessel FFR (DVFFR) delivers results nearly identical to invasive FFR in assessing intermediate coronary artery stenosis. The findings demonstrate DVFFR’s value as a precise, non-invasive tool for guiding clinical decisions and avoiding unnecessary procedures.
Advancing CCTA-Based Cardiovascular Care with Deep Learning: Highlights from Keya Medical’s SCCT 2025 Symposium
Highlights from Keya Medical’s sponsored symposium “The New World of Cardiovascular Care With CCTA: Deep Learning for Ischemia & Plaque Today – What Brings Tomorrow?”
Join Keya Medical at SCCT2025
SCCT’s 20th Annual Scientific Meeting July 17-20 | Montreal, Canada | Booth #515Keya Medical will join SCCT in Montreal to share and explore the latest innovations in cardiovascular CT. Our team will announce new research data about DV FFR, strategic partnerships, and...
